The Cor platform’s advanced ambulatory ECG capabilities transform healthcare, enabling faster, more accurate, and affordable diagnoses that enhance patients’ quality of life.
Only patented 3 lead, 2-channel wireless AECG patch with Einthoven triangle design
Proprietary algorithm to compute derived 12 lead
Explainable AI markers for Hospital Grade Indications (under trial)
Hospital-grade diagnostics and monitoring anywhere, anytime (under trial)
The Peerbridge Cor is the voice of the heart, capturing 31 rhythms with superior recording fidelity, P-wave definition, and QRS morphology.
Early detection and treatment of heart failure can significantly improve patient outcomes and alleviate the strain on healthcare systems. Peerbridge Cor’s innovative remote monitoring solution enables timely and accurate diagnosis, even in asymptomatic individuals, presenting a more accessible and cost-effective approach than traditional methods.
With Peerbridge Cor, physicians can remotely monitor and deliver an accurate heart failure diagnosis within 30 minutes of applying Cor, compared to the current diagnosis timeline of 11-15 weeks with in-hospital screening tools.
Peerbridge Health today announced the beginning of enrollment for its Ejection Fraction AI-enabled Clinical Trial (EF-ACT) pivotal trial to determine
Low-cost, Patient-friendly Platform Can Improve Patient Outcomes While Reducing Healthcare Spending.
Peerbridge Health is pleased to announce the successful completion and findings of its prospective, feasibility clinical trial, resulting in a statistically significant 91.2% predictive accuracy for the determination of apnea-hypopnea index (AHI) for diagnosing obstructive sleep apnea (OSA) while using the Peerbridge Cor.
